Successful treatment with agomelatine in NES: A series of five cases

Open Neurology Journal

Volumn 7, Issue 1, 2013, Pages 32-37

  Milano, W ^a   De Rosa, M ^a   Milano, L ^a   Riccio, A ^a   Sanseverino, B ^a   Capasso, A ^a  

^a UNIVERSITY OF SALERNO   (Italy)

Author keywords

Agomelatinae; DCA; Depression; NES

Indexed keywords

AGOMELATINE;

ADULT; AROUSAL; ARTICLE; BINGE EATING DISORDER; BODY MOVEMENT; CLINICAL ARTICLE; DEPRESSION; FEMALE; HAMILTON SCALE; HUMAN; MALE; MOOD; NIGHT EATING QUESTIONNAIRE; OUTCOME ASSESSMENT; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUESTIONNAIRE; SNORING; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

EID: 84885654085     PISSN: None     EISSN: 1874205X     Source Type: Journal    
DOI: 10.2174/1874205X20130626001     Document Type: Article

References (31)

1. Vetrugno R, Manconi M, Ferrini-Strambil L, et al Nocturnal eating sleep-related eating disorder or night eating sybdrome? A videopolysomnographic study. Sleep 2006; 29: 949-54.
2. Fassino S, Abbate-Daga G, De Filippis S, et al Sleep and eating disorders: a review. G Ital Psicopatol 2005; 11: 354-62.
3. American Psychiatric Association. Diagnostic and Statistic Manual of Mental Disorder. 4th ed. US: American Psychiatric Association 2000
4. Milano W, De Rosa M, Milano L, Capasso A. Night Eating Syndrome: an overview. Pharm Pharmacol 2012; 64 (1): 2-10.
5. Allison KC, Lundgren JD, O'Reardon JP, et al. Proposed diagnostic criteria for night eating syndrome. Int J Eat Disord 2010; 43(3): 241-7.
6. Monteleone P, Maj M. The circadian basis of mood disorders: recent developments and treatment implications. Eur Neuropsychopharmacol 2008; 18: 701-11.
7. Birketvedt G, Florgolmen J, Sundsfjord J, et al. Behavioral and neuroendocrine characteristics of the night-eating syndrome. JAMA 1999; 282: 657-63.
8. Goel N, Stunkard AJ, Rogers Nl, et al. Circadian rhythm profiles in women with night eating syndrome. J Biol Rhythms 2009; 24(1): 85-94.
9. Allison KC, Ahima RS, O' Reardon PJ, et al. Neuroendocrine profiles associated with energy intake, sleep and stress in the night eating syndrome. J Clin Endocrinol Metab 2005; 90(11): 6214-7.
10. Gluk ME, Geliebter A, Satov T. Night eating syndrome is associated with depression, low self-esteem, reduced daytime hunger and less weight loss in obese outpatients. Obes Res 2001; 9: 264-7.
11. de Zwaan M, Roerig DB, Crosby RD et al. Night-time eating: a descriptive study. Int J Eat Disord 39: 224-232 2006
12. Boseck JJ, Engel SG, Allison KC, et al The application of ecological momentary assessment to the study of night eating. J Eat Disord 2006; 40: 271-26.
13. Striegel-Moore RH, Dohm FA, Hook JM, et al. Night eating syndrome in young adult women: prevalence and correlates. Int J Eat Disord 2005; 37: 200-6.
14. de Zwann M, Burgard MA, Schenck CH, et al. Night time eating: a review of the literature. Eur Eat Disord Rev 2003; 11: 7-24.
15. Orham FO, Ozer UG, Ozer A, et al. Night Eating Syndrome among patients with depression. Isr J Psychiatry Relat Sci 2011; 48: 21-217.
16. Winkelman JW. Efficacy and tolerability of open-label topiramate in the treatment of sleep-related eating disorder: a retrospective case series. J Clin Psychiatry 2006; 67: 1729-34.
17. Miyaoka T, Yasukawa R, Tsubouchi K, et al. Successful treatment of nocturnal eating/drinking syndrome with selective serotonina reuptake inhibitors. Int Clin Psychopharmacol 2003; 18: 175-7.
18. Allison KC, Taves EP. Treatment of Night Eating Syndrome. Psychiatr Clin N Am 2011; 34: 785-96.
19. O'Reardon PJ, Allison KC, Martino NS, et al. A randomized, placebo-controlled trial of sertraline in the treatment of night eating syndrome. Am j Psychiatry 2006; 163: 893-8.
20. Hickie I B, Rogers NL. Novel melatonin-based therapies: potential advances in the treatment of major depression. Lancet 2011; 378(9791): 621-31.
21. De Bodinat C, Guardiola-Lemaitre B, Mocaer E, et al Agomelatine, the melatoninergic antidepressant: discovery, characterization and development. Nat Rev 2010; 9 (8): 628-42.
22. Paizanis E, Renoir T, Lelievre V, et al. Behavioural and neuroplastic effects of the new-generation antidepressant agomelatina compared to fluoxetina in glucocorticoid receptor-impaired mice. Int J Neuropsychopharmacol 2010; 272: 1189-96.
23. Allison KC, Lundgren JD, O'Reardon JP, et al. The night eating questionnaire (NEQ): psychometric properties of a measure of severity of the night eating syndrome. Eating Behav 2008; 9 (1): 62-72: 2008.
24. Vander Wal, Night JS. Eating Syndrome: a critical review of the literature. Clin Psycol Rev 2012; 32: 49-59.
25. Biggio G. Neurobiology and pharmacology of a new antidepressant therapy. Ital J Psychopathol 2011; 17(3): 1-6.
26. Molteni R, Calabrese F, Pisoni, et al. Synergistic mechanism in the modulation of the neurotrophin BDNF in the rat prefrontal cortex following acute agomelatine administration. World J Biol Psychiatry 2010; 11: 148-53.
27. Racagni G, Riva MA, Molteni R, et al. Mode of action of agomelatine: synergy between melatonergic and 5-HT2C receptors. World J Biol Psychiatry 2011; 12: 574-87
28. Racagni G. Meccanismi sinergici coinvolti negli effetti antidepressivi di agomelatina. G Ital Psicopatol 2012; 18(1): 2-3.
29. Allison KC, Stunkard AJ, Thier SL. Overcoming Night Eating Syndrome: A Step-by-Step Guide to Breaking the Cycle New Harbinger Oakland 2004; CA.
30. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967; 6: 278-96.
31. Vinai P, Allison KC, Cardetti S, et al. Psychopathology and treatment of night eating syndrome: a review. Eat Weight Disord 2008; 13(2): 54-63.